Table 1 Sociodemographic and clinical characteristics (N = 327)

Age

  ≤ 50

127 (38.8%)

  > 50

200 (61.2%)

Gender

  Male

103 (31.5%)

  Female

224 (68.5%)

BMI

  < 18.5 (underweight)

7 (2.1%)

  18.5–24.9 (healthy weight)

83 (25.4%)

  25–29.9 (overweight)

119 (36.4%)

  ≥ 30 (obese)

118 (36.1%)

Cancer type

  Hematological

83 (25.4%)

  Solid

244 (74.6%)

Metastasis

  No

195 (59.6%)

  Yes

132 (40.4%)

Palliative

  No

200 (61.2%)

  Yes

127 (38.8%)

Duration of treatment (years)

  < 1

193 (59.0%)

  1–3

90 (27.5%)

  > 3

44(13.5%)

Number of comorbid diseases

  0

165 (50.5)

  1

91 (27.8)

  ≥ 2

71 (21.7)

Family history

  No

173 (52.9%)

  Yes

154 (47.1%)

All drugs used

  ≤ 7

158 (48.3%)

  > 7

169 (51.7%)

Anticancer therapy

  ≤ 2

200 (61.2%)

  > 2

127 (38.8%)

Education

  Not educated

18 (5.5%)

  Standard < 5

32 (9.8%)

  Standard 5–10

105(32.1%)

  Standard 11–12

100 (30.6%)

  University qualification

72 (22.0%)

Caffeine

  No

62 (19.0%)

  Yes

265 (81.0%)

Tobacco

  No

273 (83.5%)

  Yes

54 (16.5%)

Alcohol

  No 

324 (99.1%)

  Yes

3 (0.9%)

Grapefruit

  No

230 (70.3%)

  Yes

97 (29.7%)

Herbs

  No

144 (44.0%)

  Yes

183 (56.0%)